apr-246 in tp53 mutated mds and aml
Published 3 years ago • 355 plays • Length 3:00Download video MP4
Download video MP3
Similar videos
-
3:14
apr-246 with azacitidine for p53 mutated mds and aml
-
3:03
mutant p53 re-activator apr-246 in mds/aml
-
2:58
long-term follow-up: phase ii study of apr-246 aza in tp53-mutated mds & aml
-
1:38
apr-246 and azacitidine in tp53m mds and aml
-
1:33
the current guidelines and therapies for tp53-mutated mds and aml
-
2024.08.08 八度空间华语新闻 ǁ 8pm 网络直播
-
5:23
set up installation
-
15:57
aggregasi trombosit menggunakan alat aggram by helena laboratories
-
2:48
apr-246 combination treatments in tp53-mutant r/r nhls
-
3:24
data for apr-246 and azacitidine in patients with mtp53 mds and aml
-
2:23
improving treatment for patients with tp53-mutated myeloid malignancies
-
1:26
updates in the treatment landscape of p53-mutated aml/mds
-
1:06
is there hope for treating tp53-mutated mds?
-
0:41
promising agents in aml: menin inhibitors & magrolimab in tp53-mutated aml
-
0:58
options available to patients with tp53-mutated mds beyond stem cell transplantation
-
1:57
tolerability and efficacy of magrolimab plus azacitidine in tp53-mutated aml patients
-
0:44
unmet needs in aml: tp53 mutations and maintenance therapy
-
3:19
an overview of novel treatment approaches in tp53-mutated aml
-
8:14
progress in the treatment of tp53 mutated aml
-
4:38
soho 2021 highlights: ‘targeting p53 in mds’
-
1:54
fusion-aml-001: molecular changes associated with azacitidine & durvalumab in tp53m aml and hr-mds